FDA OKs Nusinersen, First Drug for Spinal Muscular Atrophy – Medscape
Medscape |
FDA OKs Nusinersen, First Drug for Spinal Muscular Atrophy
Medscape The US Food and Drug Administration (FDA) has approved nusinersen (Spinraza, Biogen and Ionis Pharmaceuticals), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease. SMA, which … Biogen gets FDA approval for first spinal muscular atrophy treatment The FDA’s Christmas Breakthrough FDA OKs first treatment for rare genetic disorder |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.